FDA Clearance Tracker · P030028-S005
ARTISAN/VERISYSE MYOPIA PHAKIC INTRAOCULAR LENS
Last checked: Nov 20, 2026Latest source record: Aug 20, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Aug 20, 2018
Approved
Time to decision
574 days
Received Jan 23, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
Device type
- Device type
- Lens, intraocular, phakic (MTA)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for modifying the physician and patient labeling to include the results from the extended follow-up post-approval study.
Source documents
Other decisions for Ophtec BV
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.